In a prospective pilot randomised trial evaluating procedural decision strategies for drug-coated balloon treatment in non-complex coronary lesions, researchers evaluated whether a quantitative flow ratio approach could match intravascular ultrasound combined with functional confirmation. The single-centre study investigated how distinct physiological and imaging guidance strategies perform during percutaneous coronary interventions, specifically assessing whether on-line computational flow assessment combined with virtual intervention planning provides adequate post-procedural functional outcomes compared with ultrasound guidance.
Investigators sought to determine procedural feasibility and generate effect size estimates required to power future large-scale clinical trials. The trial specifically enrolled patients presenting with non-complex coronary lesions to contrast a computational functional approach directly against an intravascular imaging methodology confirmed by functional measurement.
The study protocol randomised 78 patients representing 82 target vessels in an open-label, 1:1 allocation ratio between two interventional management pathways. Among the randomised cohort, four participants contributed two distinct vessels each to the final vessel pool. Forty-three vessels were allocated to the quantitative flow ratio pathway utilizing on-line computational analysis and virtual percutaneous intervention planning, while 39 vessels underwent intravascular ultrasound guidance accompanied by quantitative flow ratio confirmation.
Immediate post-procedural functional success served as the primary trial endpoint, established strictly as an offline post-PCI quantitative flow ratio of 0.90 or greater determined by an independent core laboratory. The primary statistical effect measure was calculated as the absolute risk difference with a 95 percent confidence interval derived through patient-level cluster bootstrap methods. Primary analytical cohorts incorporated all 78 randomised patients, with primary endpoint data successfully obtained across all 82 treated vessels.
Analysis of post-procedural hemodynamics revealed that functional success was achieved in 79.1 percent of vessels in the computational flow guided arm, corresponding to 34 out of 43 lesions. Within the intravascular ultrasound plus flow confirmation arm, 84.6 percent of vessels reached functional success, accounting for 33 of 39 lesions. This comparison yielded an absolute risk difference of minus 5.5 percentage points with a 95 percent confidence interval ranging from minus 21.3 to 11.7 percentage points, alongside a covariate-adjusted odds ratio of 0.58 with a 95 percent confidence interval spanning 0.18 to 1.85.
Unplanned stent implantation occurred in three vessels, representing 7.7 percent of the intravascular ultrasound plus confirmation arm, while none occurred in the computational flow cohort. These three events comprised two intraprocedural bailout stenting procedures and one early unplanned reintervention. Notably, two of the three stented vessels had previously met the threshold for post-procedural functional success before requiring scaffold placement. When evaluating a post-hoc composite endpoint of functional success without stent implantation, rates were 79.1 percent in the flow guided arm and 79.5 percent in the ultrasound guided arm, representing an absolute risk difference of minus 0.4 percentage points with a 95 percent confidence interval from minus 17.2 to 17.5 percentage points.
The authors concluded that both intraprocedural guidance strategies were feasible for delivering drug-coated balloon therapy in non-complex coronary lesions. However, because the observed confidence intervals were wide, clinically meaningful performance differences between the two modalities cannot be ruled out. The researchers noted that these initial feasibility and effect size estimates should guide the design of future confirmatory clinical trials powered specifically for hard clinical event endpoints.
Subject of Research: Comparison of QFR-guided versus IVUS-guided strategies for drug-coated balloon angioplasty in non-complex coronary lesions
Article Title: QFR-guided versus IVUS-guided with QFR confirmation for drug-coated balloon treatment of non-complex coronary lesions: a single-centre pilot randomised trial
Article References: Zhao, X., Zhou, Q., Jiang, Y., Ye, Y., & Luo, H. (2026). QFR-guided versus IVUS-guided with QFR confirmation for drug-coated balloon treatment of non-complex coronary lesions: a single-centre pilot randomised trial. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-07055-2
Image Credits: AI Generated
DOI: 10.1186/s12872-026-07055-2
Keywords: drug-coated balloons, quantitative flow ratio, intravascular ultrasound, coronary artery disease, percutaneous coronary intervention, virtual PCI, functional success, bailout stenting, pilot randomised trial, coronary angiography, interventional cardiology, hemodynamic assessment, vessel dissection, clinical trial design, coronary lesions, cardiovascular medicine
News Source: Ophelia Keating. (November 21, 2026). Pilot Trial Tests Imaging Versus Flow Ratio for Coronary Balloon Interventions. Scienmag.



